Ribometrix Revenue and Competitors

Location

$45.3M

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • Ribometrix's estimated annual revenue is currently $3.9M per year.(i)
  • Ribometrix's estimated revenue per employee is $129,200
  • Ribometrix's total funding is $45.3M.

Employee Data

  • Ribometrix has 30 Employees.(i)
  • Ribometrix grew their employee count by -12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.3M1318%N/AN/A
#2
$3.1M2618%N/AN/A
#3
$3.9M30-12%$45.3MN/A
#4
$16.3M96N/AN/AN/A
#5
$4.9M36-27%N/AN/A
#6
$1.1M110%N/AN/A
#7
$13.4M7913%N/AN/A
Add Company

Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.

keywords:N/A

$45.3M

Total Funding

30

Number of Employees

$3.9M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ribometrix News

2022-03-30 - Movers & Shakers, March 25 | BioSpace

He also served various roles in clinical development, including at Chugai Pharma USA, Novartis. Ribometrix – Manjunath Ramarao, Ph.D., was...

2022-03-30 - RNA-Targeted Small Molecules Market Size 2022, CAGR Value, Top Key Players, Competitive Landscape and Recent

For instance, Ribometrix, Inc., a biotechnology company, announced a significant collaboration with Genentech, a member of the Roche Group,...

2022-03-22 - Ribometrix Promotes Dr. Manjunath Ramarao to Chief ...

Ribometrix is a biotechnology company pioneering a completely new class of small molecule therapeutics that directly target and modulate the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M30-3%N/A
#2
$2.4M30-9%N/A
#3
$6.5M307%N/A
#4
$2.4M3020%N/A
#5
$7.5M310%N/A